Characteristics of Patients With Missed Pulmonary Embolism in the ED: A Three Year Experience
NCT ID: NCT02476721
Last Updated: 2015-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1251 participants
OBSERVATIONAL
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence and Risk Factors of Chronic Thrombo-embolic Disease After a Pulmonary Embolism Event
NCT05073666
Prognostic Tools in Patients With Acute Pulmonary Thromboembolism.
NCT04237974
Clinical Pulmonary Embolism
NCT05469724
Thrombolytic and Interventional Treatment of Pulmonary Embolism
NCT03886194
Prognostic Factors for Acute Pulmonary Embolism in Critically Ill Patients
NCT01839266
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
detection of pulmonary embolism
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* presented to the ED between January 2011 and March 2014,
* who received an ECG or any form of thoracic imaging.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christoph Keil
Dr.med.univ.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EKNZ 2014-183
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.